Bacterial DNA delays human eosinophil apoptosis

Pulmonary Pharmacology and Therapeutics

Volumn 22, Issue 3, 2009, Pages 167-176

  Ilmarinen, Pinja ^a   Hasala, Hannele ^a   Sareila, Outi ^a   Moilanen, Eeva ^a   Kankaanranta, Hannu ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b SEINÄJOKI CENTRAL HOSPITAL   (Finland)

Author keywords

Apoptosis; Bacterial infection; CpG DNA; Eosinophil; Toll like receptor 9

Indexed keywords

BACTERIAL DNA; BUDESONIDE; CD123 ANTIGEN; CD16 ANTIGEN; CD19 ANTIGEN; CPG OLIGODEOXYNUCLEOTIDE; GLUCOCORTICOID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOCORTIN 5; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOROTHIOIC ACID; TOLL LIKE RECEPTOR 9;

ALLERGIC ASTHMA; ALLERGY; APOPTOSIS; ARTICLE; ASTHMA; ATOPY; BACTERIAL INFECTION; CONTROLLED STUDY; EOSINOPHIL; EOSINOPHILIA; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT INFLAMMATION;

ANNEXIN A5; ANTIGENS, CD19; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELLS, CULTURED; COLORING AGENTS; CPG ISLANDS; DNA METHYLATION; DNA, BACTERIAL; ENDOSOMES; EOSINOPHILS; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; GLUCOCORTICOIDS; HUMANS; INTERLEUKIN-3 RECEPTOR ALPHA SUBUNIT; OLIGONUCLEOTIDES; PNEUMONIA; PROPIDIUM; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 9;

EID: 67349207937     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2008.11.012     Document Type: Article

References (53)

1. Bousquet J., Jeffery P.K., Busse W.W., Johnson M., and Vignola A.M. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 161 (2000) 1720-1745
2. Humbles A.A., Lloyd C.M., McMillan S.J., Friend D.S., Xanthou G., McKenna E.E., et al. A critical role for eosinophils in allergic airways remodeling. Science 305 (2004) 1776-1779 10.1126/science.1100283
3. Fulkerson P.C., Fischetti C.A., McBride M.L., Hassman L.M., Hogan S.P., and Rothenberg M.E. A central regulatory role for eosinophils and the eotaxin/CCR3 axis in chronic experimental allergic airway inflammation. Proc Natl Acad Sci U S A 103 (2006) 16418-16423 10.1073/pnas.0607863103
4. Kankaanranta H., Lindsay M.A., Giembycz M.A., Zhang X., Moilanen E., and Barnes P.J. Delayed eosinophil apoptosis in asthma. J Allergy Clin Immun 106 (2000) 77-83
5. Martin R.J. Infections and asthma. Clin Chest Med 27 (2006) 87-98 10.1016/j.ccm.2005.10.004
6. Johnston S.L., and Martin R.J. Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis?. Am J Respir Crit Care Med 172 (2005) 1078-1089 10.1164/rccm.200412-1743PP
7. Friedman R., Ackerman M., Wald E., Casselbrant M., Friday G., and Fireman P. Asthma and bacterial sinusitis in children. J Allergy Clin Immunol 74 (1984) 185-189
8. Jatakanon A., Lim S., and Barnes P.J. Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med 161 (2000) 64-72
9. in't Veen J.C., Smits H.H., Hiemstra P.S., Zwinderman A.E., Sterk P.J., and Bel E.H. Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal. Am J Respir Crit Care Med 160 (1999) 93-99
10. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., et al. A toll-like receptor recognizes bacterial DNA. Nature 408 (2000) 740-745 10.1038/35047123
11. Schwartz D.A., Quinn T.J., Thorne P.S., Sayeed S., Yi A.K., and Krieg A.M. CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract. J Clin Invest 100 (1997) 68-73
12. Jain V.V., Businga T.R., Kitagaki K., George C.L., O'Shaughnessy P.T., and Kline J.N. Mucosal immunotherapy with CpG oligodeoxynucleotides reverses a murine model of chronic asthma induced by repeated antigen exposure. Am J Physiol Lung Cell Mol Physiol 285 (2003) L1137-L1146
13. Santeliz J.V., Van Nest G., Traquina P., Larsen E., and Wills-Karp M. Amb a 1-linked CpG oligodeoxynucleotides reverse established airway hyperresponsiveness in a murine model of asthma. J Allergy Clin Immun 109 (2002) 455-462
14. Klinman D.M. Immunotherapeutic uses of CpG oligodeoxynucleotides. Immunology 4 (2004) 249-258
15. Nagase H., Okugawa S., Ota Y., Yamaguchi M., Tomizawa H., Matsushima K., et al. Expression and function of toll-like receptors in eosinophils: activation by toll-like receptor 7 ligand. J Immunol 171 (2003) 3977-3982
16. Wong C.K., Cheung P.F., Ip W.K., and Lam C.W. Intracellular signaling mechanisms regulating toll-like receptor-mediated activation of eosinophils. Am J Respir Cell Mol Biol (2007) 10.1165/rcmb.2006-0457
17. Zhang X., Moilanen E., and Kankaanranta H. Enhancement of human eosinophil apoptosis by fluticasone propionate, budesonide, and beclomethasone. Eur J Pharmacol 406 (2000) 325-332
18. Zhang X., Moilanen E., Adcock I.M., Lindsay M.A., and Kankaanranta H. Divergent effect of mometasone on human eosinophil and neutrophil apoptosis. Life Sci 71 (2002) 1523-1534
19. Kankaanranta H., Ilmarinen P., Zhang X., Nissinen E., and Moilanen E. Antieosinophilic activity of orazipone. Mol Pharmacol 69 (2006) 1861-1870 10.1124/mol.105.021170
20. Matsumoto K., Terakawa M., Fukuda S., Kato A., Toki S., Shinohara M., et al. CpG oligodeoxynucleotide prolongs eosinophil survival through activation of contaminating B cells and plasmacytoid dendritic cells in vitro. Int Arch Allergy Immunol 140 Suppl. 1 (2006) 42-50 10.1159/000092710
21. Uller L., Andersson M., Greiff L., Persson C.G., and Erjefalt J.S. Occurrence of apoptosis, secondary necrosis, and cytolysis in eosinophilic nasal polyps. Am J Respir Crit Care Med 170 (2004) 742-747 10.1164/rccm.200402-240
22. Blackwell S.E., and Krieg A.M. CpG-A-induced monocyte IFN-gamma-inducible protein-10 production is regulated by plasmacytoid dendritic cell-derived IFN-alpha. J Immunol 170 (2003) 4061-4068
23. Latz E., Verma A., Visintin A., Gong M., Sirois C.M., Klein D.C., et al. Ligand-induced conformational changes allosterically activate toll-like receptor 9. Nat Immunol 8 (2007) 772-779 10.1038/ni1479
24. Ishii K.J., Takeshita F., Gursel I., Gursel M., Conover J., Nussenzweig A., et al. Potential role of phosphatidylinositol 3 kinase, rather than DNA-dependent protein kinase, in CpG DNA-induced immune activation. J Exp Med 196 (2002) 269-274
25. Ward C., Chilvers E.R., Lawson M.F., Pryde J.G., Fujihara S., Farrow S.N., et al. NF-kappaB activation is a critical regulator of human granulocyte apoptosis in vitro. J Biol Chem 274 (1999) 4309-4318
26. Virchow Jr. J.C., Walker C., Hafner D., Kortsik C., Werner P., Matthys H., et al. T cells and cytokines in bronchoalveolar lavage fluid after segmental allergen provocation in atopic asthma. Am J Respir Crit Care Med 151 (1995) 960-968
27. Druilhe A., Wallaert B., Tsicopoulos A., Lapa e Silva J.R., Tillie-Leblond I., Tonnel A.B., et al. Apoptosis, proliferation, and expression of Bcl-2, Fas, and Fas ligand in bronchial biopsies from asthmatics. Am J Respir Cell Mol Biol 19 (1998) 747-757
28. Wallen N., Kita H., Weiler D., and Gleich G.J. Glucocorticoids inhibit cytokine-mediated eosinophil survival. J Immunol 147 (1991) 3490-3495
29. Machida K., Inoue H., Matsumoto K., Tsuda M., Fukuyama S., Koto H., et al. Activation of PI3 K-Akt pathway mediates antiapoptotic effects of beta-adrenergic agonist in airway eosinophils. Am J Physiol Lung Cell Mol Physiol 288 (2005) L860-L867 10.1152/ajplung.00131.2004
30. Peacock C.D., Misso N.L., Watkins D.N., and Thompson P.J. PGE 2 and dibutyryl cyclic adenosine monophosphate prolong eosinophil survival in vitro. J Allergy Clin Immunol 104 (1999) 153-162 doi: 10.1016/S0091-6749(99)70127-2
31. Hartmann G., Weiner G.J., and Krieg A.M. CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc Natl Acad Sci USA 96 (1999) 9305-9310
32. Yi A.K., Chang M., Peckham D.W., Krieg A.M., and Ashman R.F. CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry. J Immunol 160 (1998) 5898-5906
33. Jozsef L., Khreiss T., and Filep J.G. CpG motifs in bacterial DNA delay apoptosis of neutrophil granulocytes. FASEB J 18 (2004) 1776-1778 10.1096/fj.04-2048fje
34. Rutz M., Metzger J., Gellert T., Luppa P., Lipford G.B., Wagner H., et al. Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner. Eur J Immunol 34 (2004) 2541-2550 10.1002/eji.200425218
35. Maxfield F.R. Weak bases and ionophores rapidly and reversibly raise the pH of endocytic vesicles in cultured mouse fibroblasts. J Cell Biol 95 (1982) 676-681
36. Allison J.L., O'Brien R.L., and Hahn F.E. DNA: reaction with chloroquine. Science 149 (1965) 1111-1113
37. Too C.K. Rapid induction of Jak2 and Sp1 in T cells by phosphorothioate oligonucleotides. Antisense Nucleic Acid Drug Dev 8 (1998) 87-94
38. Bylund J., Samuelsson M., Tarkowski A., Karlsson A., and Collins L.V. Immunostimulatory DNA induces degranulation and NADPH-oxidase activation in human neutrophils while concomitantly inhibiting chemotaxis and phagocytosis. Eur J Immunol 32 (2002) 2847-2856
39. Giembycz M.A., and Lindsay M.A. Pharmacology of the eosinophil. Pharmacol Rev 51 (1999) 213-340
40. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374 (1995) 546-549 10.1038/374546a0
41. Bauer S., Kirschning C.J., Hacker H., Redecke V., Hausmann S., Akira S., et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci U S A 98 (2001) 9237-9242 10.1073/pnas.161293498
42. Roberts T.L., Sweet M.J., Hume D.A., and Stacey K.J. Cutting edge: species-specific TLR9-mediated recognition of CpG and non-CpG phosphorothioate-modified oligonucleotides. J Immunol 174 (2005) 605-608
43. Vollmer J., Weeratna R.D., Jurk M., Samulowitz U., McCluskie M.J., Payette P., et al. Oligodeoxynucleotides lacking CpG dinucleotides mediate toll-like receptor 9 dependent T helper type 2 biased immune stimulation. Immunology 113 (2004) 212-222
44. Trevani A.S., Chorny A., Salamone G., Vermeulen M., Gamberale R., Schettini J., et al. Bacterial DNA activates human neutrophils by a CpG-independent pathway. Eur J Immunol 33 (2003) 3164-3174
45. Kandimalla E.R., Bhagat L., Zhu F.G., Yu D., Cong Y.P., Wang D., et al. A dinucleotide motif in oligonucleotides shows potent immunomodulatory activity and overrides species-specific recognition observed with CpG motif. Proc Natl Acad Sci U S A 100 (2003) 14303-14308 10.1073/pnas.2335947100
46. Hartmann G., and Krieg A.M. Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J Immunol 164 (2000) 944-953
47. Pinho V., Souza D.G., Barsante M.M., Hamer F.P., De Freitas M.S., Rossi A.G., et al. Phosphoinositide-3 kinases critically regulate the recruitment and survival of eosinophils in vivo: importance for the resolution of allergic inflammation. J Leukoc Biol 77 (2005) 800-810 10.1189/jlb.0704386
48. Park Y., Lee S.W., and Sung Y.C. Cutting edge: CpG DNA inhibits dendritic cell apoptosis by up-regulating cellular inhibitor of apoptosis proteins through the phosphatidylinositide-3'-OH kinase pathway. J Immunol 168 (2002) 5-8
49. Ozes O.N., Mayo L.D., Gustin J.A., Pfeffer S.R., Pfeffer L.M., and Donner D.B. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401 (1999) 82-85 10.1038/43466
50. Strassheim D., Asehnoune K., Park J.S., Kim J.Y., He Q., Richter D., et al. Phosphoinositide 3-kinase and Akt occupy central roles in inflammatory responses of toll-like receptor 2-stimulated neutrophils. J Immunol 172 (2004) 5727-5733
51. Creticos P.S., Schroeder J.T., Hamilton R.G., Balcer-Whaley S.L., Khattignavong A.P., Lindblad R., et al. Immune Tolerance Network Group. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. N Engl J Med 355 (2006) 1445-1455 10.1056/NEJMoa052916
52. Gauvreau G.M., Hessel E.M., Boulet L.P., Coffman R.L., and O'byrne P.M. Immunostimulatory sequences regulate interferon-inducible genes but not allergic airway responses. Am J Respir Crit Care Med 174 (2006) 15-20 10.1164/rccm.200601-057
53. Bunikowski R., Mielke M.E., Skarabis H., Worm M., Anagnostopoulos I., Kolde G., et al. Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis. J Allergy Clin Immunol 105 (2000) 814-819 10.1067/mai.2000.105528